Cargando…
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
Therapeutic drug and immunogenicity monitoring (TDIM) is increasingly proposed to guide therapy with biologics, characterised by high inter-individual variability of their blood levels, to permit objective decisions for the management of non-responders and reduce unnecessary interventions with these...
Autores principales: | Beeg, Marten, Nobili, Alessandro, Orsini, Barbara, Rogai, Francesca, Gilardi, Daniela, Fiorino, Gionata, Danese, Silvio, Salmona, Mario, Garattini, Silvio, Gobbi, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376047/ https://www.ncbi.nlm.nih.gov/pubmed/30765716 http://dx.doi.org/10.1038/s41598-018-37950-4 |
Ejemplares similares
-
Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera
por: Beeg, Marten, et al.
Publicado: (2021) -
A portable optical-fibre-based surface plasmon resonance biosensor for the detection of therapeutic antibodies in human serum
por: Zeni, Luigi, et al.
Publicado: (2020) -
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts
por: Allocca, Mariangela, et al.
Publicado: (2020) -
Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
por: Allocca, Mariangela, et al.
Publicado: (2020) -
Protecting patients with IBD during the COVID-19 pandemic
por: Fiorino, Gionata, et al.
Publicado: (2020)